119 related articles for article (PubMed ID: 17912028)
21. Expression of growth factors and their receptors in human esophageal carcinomas: regulation of expression by epidermal growth factor and transforming growth factor alpha.
Yoshida K; Kuniyasu H; Yasui W; Kitadai Y; Toge T; Tahara E
J Cancer Res Clin Oncol; 1993; 119(7):401-7. PubMed ID: 8491760
[TBL] [Abstract][Full Text] [Related]
22. No association between epidermal growth factor and epidermal growth factor receptor polymorphisms and nasopharyngeal carcinoma.
Gao LB; Wei YS; Zhou B; Wang YY; Liang WB; Li C; Li Y; Bai P; Fang WL; Xue H; Zhang L
Cancer Genet Cytogenet; 2008 Sep; 185(2):69-73. PubMed ID: 18722874
[TBL] [Abstract][Full Text] [Related]
23. An association between EGF and EGFR gene polymorphisms with gastric cancer in a Chinese Han population.
Yang G; Rao L; Tian L; Cai X
Hepatogastroenterology; 2012; 59(120):2668-71. PubMed ID: 22534548
[TBL] [Abstract][Full Text] [Related]
24. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.
Sathyan KM; Nalinakumari KR; Abraham T; Kannan S
Oral Oncol; 2008 Jul; 44(7):689-97. PubMed ID: 18061526
[TBL] [Abstract][Full Text] [Related]
25. Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck.
Holley SL; Parkes G; Matthias C; Bockmühl U; Jahnke V; Leder K; Strange RC; Fryer AA; Hoban PR
Am J Pathol; 2001 Nov; 159(5):1917-24. PubMed ID: 11696452
[TBL] [Abstract][Full Text] [Related]
26. Clinical Implication of EGF A61G Polymorphism in the Risk of Non Small Cell Lung Adenocarcinoma Patients: A Case Control Study.
Masroor M; Amit J; Javid J; Mir R; Prasant Y; Imtiyaz A; Mariyam Z; Mohan A; Ray PC; Saxena A
Asian Pac J Cancer Prev; 2015; 16(17):7529-34. PubMed ID: 26625757
[TBL] [Abstract][Full Text] [Related]
27. Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx.
Rydzanicz M; Golusinski P; Mielcarek-Kuchta D; Golusinski W; Szyfter K
Eur Arch Otorhinolaryngol; 2006 Jan; 263(1):43-8. PubMed ID: 16258756
[TBL] [Abstract][Full Text] [Related]
28. Correlation of FCGR3A and EGFR germline polymorphisms with the efficacy of cetuximab in KRAS wild-type metastatic colorectal cancer.
Pander J; Gelderblom H; Antonini NF; Tol J; van Krieken JH; van der Straaten T; Punt CJ; Guchelaar HJ
Eur J Cancer; 2010 Jul; 46(10):1829-34. PubMed ID: 20418097
[TBL] [Abstract][Full Text] [Related]
29. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
[TBL] [Abstract][Full Text] [Related]
30. Genetic variations in EGF and EGFR and glioblastoma outcome.
Sjöström S; Andersson U; Liu Y; Brännström T; Broholm H; Johansen C; Collatz-Laier H; Henriksson R; Bondy M; Melin B
Neuro Oncol; 2010 Aug; 12(8):815-21. PubMed ID: 20197289
[TBL] [Abstract][Full Text] [Related]
31. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
[TBL] [Abstract][Full Text] [Related]
32. Essential role of polymorphism of Gab1, EGFR, and EGF for the susceptibility of biliary tract cancer.
Meng LQ
Tumour Biol; 2014 Dec; 35(12):12497-508. PubMed ID: 25217982
[TBL] [Abstract][Full Text] [Related]
33. EGFR intron-1 CA repeat polymorphism is a predictor of relapse and survival in complete resected only surgically treated esophageal cancer.
Vashist YK; Trump F; Gebauer F; Kutup A; Güngör C; Kalinin V; Muddasar R; Vettorazzi E; Yekebas EF; Brandt B; Pantel K; Izbicki JR
Target Oncol; 2014 Mar; 9(1):43-52. PubMed ID: 23377570
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of the expression of epidermal growth factor and its receptor in esophageal cancer.
Mukaida H; Toi M; Hirai T; Yamashita Y; Toge T
Cancer; 1991 Jul; 68(1):142-8. PubMed ID: 2049734
[TBL] [Abstract][Full Text] [Related]
35. Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study.
Zheng Y; Shen H; Sturgis EM; Wang LE; Eicher SA; Strom SS; Frazier ML; Spitz MR; Wei Q
Carcinogenesis; 2001 Aug; 22(8):1195-9. PubMed ID: 11470749
[TBL] [Abstract][Full Text] [Related]
36. Epidermal growth factor induces cyclin D1 in human pancreatic carcinoma: evidence for a cyclin D1-dependent cell cycle progression.
Poch B; Gansauge F; Schwarz A; Seufferlein T; Schnelldorfer T; Ramadani M; Beger HG; Gansauge S
Pancreas; 2001 Oct; 23(3):280-7. PubMed ID: 11590324
[TBL] [Abstract][Full Text] [Related]
37. Lack of association between Cyclin D1 gene G870A polymorphism and esophageal cancer: evidence from a meta-analysis.
Cai W; Wang ZT; Zhong J; Zhang Y
Genet Mol Res; 2013 Apr; 12(4):6636-45. PubMed ID: 23661400
[TBL] [Abstract][Full Text] [Related]
38. Association of selected variants in genes involved in cell cycle and apoptosis with bladder cancer risk in North Indian population.
Gangwar R; Mittal RD
DNA Cell Biol; 2010 Jul; 29(7):349-56. PubMed ID: 20380574
[TBL] [Abstract][Full Text] [Related]
39. Epidermal growth factor receptor, p53 mutation, and pathological response predict survival in patients with locally advanced esophageal cancer treated with preoperative chemoradiotherapy.
Gibson MK; Abraham SC; Wu TT; Burtness B; Heitmiller RF; Heath E; Forastiere A
Clin Cancer Res; 2003 Dec; 9(17):6461-8. PubMed ID: 14695149
[TBL] [Abstract][Full Text] [Related]
40. A NEIL1 single nucleotide polymorphism (rs4462560) predicts the risk of radiation-induced toxicities in esophageal cancer patients treated with definitive radiotherapy.
Chen Y; Zhu M; Zhang Z; Jiang G; Fu X; Fan M; Sun M; Wei Q; Zhao K
Cancer; 2013 Dec; 119(23):4205-11. PubMed ID: 24022861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
